In a case management order issued on June 28, Judge David Campbell presiding over the established Bard IVC filter MDL confirmed three lawsuits as the next bellwether trials. The trials are scheduled for September 2018, November 2018, and February 2019, respectively.
The first bellwether trial against Bard concluded with a $3.6 million verdict favoring the plaintiff while the jury sided with the defendant in the second bellwether trial on June 1, 2018. Lawsuits claim blood clot filters sold by C.R. Bard are defectively designed and tend to rupture and injure internal organs.
More than 3,500 Bard IVC lawsuits are filed against the manufacturer, which were centralized as part of a multidistrict litigation (MDL No. 2641; In Re: Bard IVC Filters Products Liability Litigation) on August 17, 2015, in the U.S. District Court District of Arizona. The outcome of these bellwether trials will be closely observed by other parties involved in the litigation for proceeding with eventual settlement negotiations.
